Investigating the Role of Thiazide-Like Diuretics in Acute Heart Failure: Potential Approach to an Unmet Need

Journal of Cardiac Failure

Volumn 22, Issue 7, 2016, Pages 537-538

  Patterson, J Herbert ^a   Adams, Kirkwood F ^b  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDROFLUMETHIAZIDE; CHLOROTHIAZIDE DERIVATIVE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOLAZONE; SULFONAMIDE; THIAZIDE DIURETIC AGENT; TOLVAPTAN; DIURETIC AGENT;

ACUTE HEART FAILURE; BODY WEIGHT; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DEHYDRATION; DYSPNEA; EDITORIAL; ELECTROLYTE DISTURBANCE; GLOMERULUS FILTRATION RATE; HENLE LOOP; HUMAN; HYPERTROPHY; HYPERVOLEMIA; KIDNEY DISTAL TUBULE; KIDNEY FUNCTION; LIKERT SCALE; PRIORITY JOURNAL; VISUAL ANALOG SCALE; ACUTE DISEASE; HEALTH SERVICE; HEART FAILURE;

ACUTE DISEASE; DIURETICS; HEALTH SERVICES NEEDS AND DEMAND; HEART FAILURE; HUMANS; THIAZIDES;

EID: 84969699823     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.05.001     Document Type: Editorial

References (13)

1. 1 Aronson, J., An account of the foxglove and its medical uses. 1985, Oxford University Press.
2. 2 Ventura, H.O., Mehra, M.R., Young, J.B., Treatment of heart failure according to William Stokes: the enchanted mercury. J Card Fail 7 (2001), 277–282.
3. 3 Brater, D.C., Update in diuretic therapy: clinical pharmacology. Semin Nephrol 31 (2011), 483–494.
4. 4 Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
5. 5 Costanzo, M.R., Saltzberg, M.T., Jessup, M., Teerlink, J.R., Sobotka, P.A., Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 16 (2010), 277–284.
6. 6 Lala, A.D.S., Vader, J., Zakeri, R., Ravichandran, A., AbouEzzadine, O., Khazanie, P., et al. A two-symptom congestion score in relation to outcomes after discharge with acute decompensated heart failure. J Card Fail, 19, 2013.
7. 7 Felker, G.M., Mentz, R.J., Adams, K.F., Cole, R.T., Egnaczyk, G.F., Patel, C.B., et al. Tolvaptan in patients hospitalized with acute heart failure: rationale and design of the TACTICS and the SECRET of CHF trials. Circ Heart Fail 8 (2015), 997–1005.
8. 8 Trullàs, J.C., Morales-Rull, J.L., Casado, J., Freitas Ramírez, A., Manzano, L., Formiga, F., et al. Rationale and design of the “Safety and Efficacy of the Combination of Loop with Thiazide-type Diurectics in Patients with Decompensated Heart Failure (CLOROTIC) Trial”: a double-blind, randomized, placebo-controlled study to dtermine the effect of combined diuretic therapy (loop diuretics with thiazide-type diuretics) among patients with decompensated heart failure. J Card Fail, 2015, 10.1016/j.cardfail.2015.11.003.
9. 9 Channer, K.S., McLean, K.A., Lawson-Matthew, P., Richardson, M., Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 71 (1994), 146–150.
10. 10 Jentzer, J.C., DeWald, T.A., Hernandez, A.F., Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 56 (2010), 1527–1534.
11. 11 Reubi, F.C., Cottier, P.T., Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation 23 (1961), 200–210.
12. 12 Pang, P.S., Gheorghiade, M., Dihu, J., Swedberg, K., Khan, S., Maggioni, A.P., et al. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials. Am Heart J 161 (2011), 1067–1072.
13. 13 Kociol, R.D., McNulty, S.E., Hernandez, A.F., Lee, K.L., Redfield, M.M., Tracy, R.P., et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 6 (2013), 240–245.